This topic contains a solution. Click here to go to the answer

Author Question: When starting a patient on antidysrhythmic therapy, the nurse will remember that which problem is ... (Read 60 times)

lb_gilbert

  • Hero Member
  • *****
  • Posts: 588
When starting a patient on antidysrhythmic
 
  therapy, the nurse will remember that which problem is a potential adverse effect of any antidysrhythmic drug?
  a. Deficiency of fat-soluble vitamins
  b. Hyperkalemia
  c. Heart failure
  d. Dysrhythmias

Question 2

A patient has been started on therapy of a
 
  continuous infusion of lidocaine after receiving a loading dose of the drug. The nurse will monitor the patient for which adverse effect?
  a. Drowsiness
  b. Nystagmus
  c. Dry mouth
  d. Convulsions



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dudman123

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

ANS: D

Answer to Question 2

ANS: D





 

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library